http://blogs.law.harvard.edu/tech/rssResearch Newshttp://www.antibodies-online.com/news/3/Research+News/Research Newsen2005-2008 antibodies-online GmbHantibodies-online GmbH RSS Feednews@antikoerper-online.de (Alexander Golubowitsch)news@antikoerper-online.de (Tim Hiddemann)Thu, 09 Feb 2012 15:34:00 +0100Sat, 11 Feb 2012 06:33:39 +0100720news@antikoerper-online.de (David Kitz Kramer)Thu, 09 Feb 2012 15:34:00 +0100Research NewsNakaa Nanotechnology Network NNN - a promising international scientific Network based in Egypt- in cooperation with iSeS Egypt are organizing the international Conference: Nanotechnology, Biotechnology and Spectroscopy, Tools of success in the coming era in the period from 1 to 3 March 2012 in Giza , the second capital of Egypt.http://www.antibodies-online.com/news/3/1044/Conference+ICNBS+Egypt+2012/http://www.antibodies-online.com/news/3/1044/Conference+ICNBS+Egypt+2012/news@antikoerper-online.de (David Kitz Kramer)Thu, 02 Feb 2012 11:02:00 +0100Research NewsThe Heidelberg Forum for Young Life Scientists is an international, inter-institutional and interdisciplinary symposium organized by a group of PhD students from different research institutes in Heidelberg: Heidelberg University Biochemistry Center (BZH), the German Cancer Research Center (DKFZ), the European Molecular Biology Laboratory (EMBL), the Max Plank Institute for Medical Research (MPI), the Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology (HBIGS), Cell Networks, and the Center for Molecular Biology Heidelberg (ZMBH).http://www.antibodies-online.com/news/3/1043/Heidelberg+Forum+for+Young+Life+Scientists/http://www.antibodies-online.com/news/3/1043/Heidelberg+Forum+for+Young+Life+Scientists/news@antikoerper-online.de (David Kitz Kramer)Thu, 12 Jan 2012 12:50:00 +0100Research NewsCapitalize on R&D and Bioprocessing Capabilities of China’s Biopharma Industry and International Partnership. BioChina International Conference 2012 is positioned to be the largest biopharma conference in China to focus on latest bioprocess and antibody advancement in China and globally.http://www.antibodies-online.com/news/3/1026/BioChina+International+2012/http://www.antibodies-online.com/news/3/1026/BioChina+International+2012/news@antikoerper-online.de (David Kitz Kramer)Thu, 12 Jan 2012 12:49:00 +0100Research NewsThe Biomanufacturing Summit has been designed to provide you with essential coverage dedicated to manufacturing excellence and quality including: Managing Quality on a Global Scale: What do the Q10 harmonization guidelines mean and how can it help your organization?http://www.antibodies-online.com/news/3/1025/Biomanufacturing+Summit+2012/http://www.antibodies-online.com/news/3/1025/Biomanufacturing+Summit+2012/news@antikoerper-online.de (David Kitz Kramer)Fri, 06 Jan 2012 16:43:00 +0100Research NewsThis multi-disciplinary conference aims to provide a challenging forum and vibrant opportunity for researchers and industry practitioners to share their original research results and practical development experiences on specific new challenges and emerging issues.http://www.antibodies-online.com/news/3/1024/2nd+Annual+International+Conference+on+Advances+in+Biotechnology+BIOTECH+2012/http://www.antibodies-online.com/news/3/1024/2nd+Annual+International+Conference+on+Advances+in+Biotechnology+BIOTECH+2012/news@antikoerper-online.de (David Kitz Kramer)Fri, 16 Dec 2011 14:01:00 +0100Research NewsAttend our event to explore effective strategies to gain competitive advantage and understand the role of safety biomarkers in clinical development.http://www.antibodies-online.com/news/3/1020/Conference+2nd+annual+Clinical+Trials+in+Oncology/http://www.antibodies-online.com/news/3/1020/Conference+2nd+annual+Clinical+Trials+in+Oncology/news@antikoerper-online.de (David Kitz Kramer)Fri, 16 Dec 2011 13:57:00 +0100Research NewsWith the increasing demand for eligible study patient populations as well as the need for more cost-efficient clinical development programs, the CEE and CIS region represents an attractive location for pharma companies to conduct clinical trials.http://www.antibodies-online.com/news/3/1019/Conference+5th+Annual+CEE++CIS+Clinical+Trials+Forum/http://www.antibodies-online.com/news/3/1019/Conference+5th+Annual+CEE++CIS+Clinical+Trials+Forum/news@antikoerper-online.de (David Kitz Kramer)Wed, 23 Nov 2011 11:05:00 +0100Research NewsNetwork with more than 4,000 decision makers in Asia's largest BioPharma gathering! Are you able to find the right partners to expand throughout Asia? Has funding ever been a constraint to your development? Has cost-efficiency become more and more crucial in your agenda?http://www.antibodies-online.com/news/3/988/BioPharma+Asia+Convention+2012/http://www.antibodies-online.com/news/3/988/BioPharma+Asia+Convention+2012/news@antikoerper-online.de (David Kitz Kramer)Fri, 28 Oct 2011 12:42:00 +0200Research NewsThe 2nd World Congress on Analytical and Bioanalytical Techniques is a unique opportunity to update your knowledge of the latest research and manufacturing technologies on bioanalytical and analytical studies. http://www.antibodies-online.com/news/3/947/2nd+World+Congress+on+Analytical+and+Bioanalytical+Techniques/http://www.antibodies-online.com/news/3/947/2nd+World+Congress+on+Analytical+and+Bioanalytical+Techniques/news@antikoerper-online.de (David Kitz Kramer)Thu, 27 Oct 2011 10:12:00 +0200Research NewsCancer is the fastest growing healthcare priority within the pharmaceutical industry worldwide and is of great commercial importance. With over 20 million new strands of cancer predicted to evolve in 2025, (according to the WHO), it corresponds that research devoted to improving the treatment of oncology is set to increase exponentially. http://www.antibodies-online.com/news/3/946/2nd+Annual+Clinical+Trials+in+Oncology+Conference/http://www.antibodies-online.com/news/3/946/2nd+Annual+Clinical+Trials+in+Oncology+Conference/news@antikoerper-online.de (David Kitz Kramer)Thu, 27 Oct 2011 10:01:00 +0200Research NewsEnsuring the high quality of your clinical data in an era of cost cutting: With 20 - 35% of millions of euros being invested in multinational clinical trials being spent on data management, this sector is one of the most important assets of large Pharmaceutical companies and clinical research organizations. http://www.antibodies-online.com/news/3/945/Conference+Data+Management+in+Clinical+Trials/http://www.antibodies-online.com/news/3/945/Conference+Data+Management+in+Clinical+Trials/news@antikoerper-online.de (David Kitz Kramer)Wed, 19 Oct 2011 15:30:00 +0200Research NewsA renowned group of leading international speakers will convene in London from November 29 – 30, 2011 to discuss the obstacles medical professionals face when screening for ovarian cancer. http://www.antibodies-online.com/news/3/941/International+Conference+on+Ovarian+Cancer+Screening+2011+/http://www.antibodies-online.com/news/3/941/International+Conference+on+Ovarian+Cancer+Screening+2011+/news@antikoerper-online.de (David Kitz Kramer)Wed, 19 Oct 2011 15:20:00 +0200Research NewsWith 20 - 35% of millions of euros being invested in multinational clinical trials being spent on data management, this sector is one of the most important assets of large Pharmaceutical companies and clinical research organizations.http://www.antibodies-online.com/news/3/940/Conference+Ensuring+the+high+quality+of+your+clinical+data+in+an+era+of+cost+cutting/http://www.antibodies-online.com/news/3/940/Conference+Ensuring+the+high+quality+of+your+clinical+data+in+an+era+of+cost+cutting/news@antikoerper-online.de (David Kitz Kramer)Thu, 06 Oct 2011 11:52:00 +0200Research NewsAs a subscriber of antibodies-online.com, we are pleased to offer you a 15% discount when you register at our World Stem Cells & Regenerative Medicine Congress Asia2011! This is your final chance in 2011 to find out the latest on stem cell and regenerative medicine in Asia. http://www.antibodies-online.com/news/3/934/Conference+World+Stem+Cells++Regenerative+Medicine+Congress+Asia+2011/http://www.antibodies-online.com/news/3/934/Conference+World+Stem+Cells++Regenerative+Medicine+Congress+Asia+2011/news@antikoerper-online.de (David Kitz Kramer)Thu, 15 Sep 2011 12:06:00 +0200Research NewsThe way from product development to manufacturing of Biopharmaceuticals, Biosimilars and Biologics is complex, time-consuming and risky. http://www.antibodies-online.com/news/3/920/Conference+Vaccines+and+Biologics/http://www.antibodies-online.com/news/3/920/Conference+Vaccines+and+Biologics/